Dr. Connelly is Vice President, Research, at Synthetic Biologics, Inc., a clinical-stage company focused on gut microbiome therapeutics to protect and restore patient health. She has over 20 years of experience in the biotechnology and pharmaceutical industries ranging from start-ups to large pharma. She served as VP Research at GrayBug Vision, Inc. and cofounded Advanced Vision Therapies, Inc., both ocular therapeutic startups, and as Group Leader at Genetic Therapy, Inc., a Novartis Company. Dr. Connelly earned her PhD in Molecular Biology from Columbia University and completed postdoctoral training at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland.
Follow on: Twitter: @sconnelly4232